820 related articles for article (PubMed ID: 17332810)
1. [Cannabis and cannabinoids as drugs].
Khiabani HZ; Mørland J
Tidsskr Nor Laegeforen; 2007 Mar; 127(5):579-82. PubMed ID: 17332810
[TBL] [Abstract][Full Text] [Related]
2. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
Pertwee RG
Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
[TBL] [Abstract][Full Text] [Related]
3. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.
van Amsterdam J; Brunt T; van den Brink W
J Psychopharmacol; 2015 Mar; 29(3):254-63. PubMed ID: 25586398
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of cannabinoids.
Grotenhermen F
Clin Pharmacokinet; 2003; 42(4):327-60. PubMed ID: 12648025
[TBL] [Abstract][Full Text] [Related]
5. Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.
Krebs MO; Kebir O; Jay TM
Eur J Pain; 2019 Aug; 23(7):1225-1233. PubMed ID: 30793421
[TBL] [Abstract][Full Text] [Related]
6. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
[TBL] [Abstract][Full Text] [Related]
7. Perinatal exposure to Δ9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens.
Lombard C; Hegde VL; Nagarkatti M; Nagarkatti PS
J Pharmacol Exp Ther; 2011 Nov; 339(2):607-17. PubMed ID: 21831965
[TBL] [Abstract][Full Text] [Related]
8. Designer Drugs 2.0.
Huestis MA; Tyndale RF
Clin Pharmacol Ther; 2017 Feb; 101(2):152-157. PubMed ID: 28084644
[TBL] [Abstract][Full Text] [Related]
9. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
McCarberg BH; Barkin RL
Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
[TBL] [Abstract][Full Text] [Related]
10. [Tetrahydrocannabinol pharmacokinetics; new synthetic cannabinoids; road safety and cannabis].
Goullé JP; Guerbet M
Bull Acad Natl Med; 2014 Mar; 198(3):541-56; discussion 556-7. PubMed ID: 26427296
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology and effects of cannabis: a brief review.
Ashton CH
Br J Psychiatry; 2001 Feb; 178():101-6. PubMed ID: 11157422
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids.
Grotenhermen F
Curr Drug Targets CNS Neurol Disord; 2005 Oct; 4(5):507-30. PubMed ID: 16266285
[TBL] [Abstract][Full Text] [Related]
13. The effect of Delta9-tetrahydrocannabinol on sensorimotor gating in socially isolated rats.
Malone DT; Taylor DA
Behav Brain Res; 2006 Jan; 166(1):101-9. PubMed ID: 16143410
[TBL] [Abstract][Full Text] [Related]
14. A molecular basis of the therapeutic and psychoactive properties of cannabis (delta9-tetrahydrocannabinol).
Nahas G; Harvey DJ; Sutin K; Turndorf H; Cancro R
Prog Neuropsychopharmacol Biol Psychiatry; 2002 May; 26(4):721-30. PubMed ID: 12188105
[TBL] [Abstract][Full Text] [Related]
15. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.
Lile JA; Kelly TH; Hays LR
Drug Alcohol Depend; 2011 Jul; 116(1-3):86-92. PubMed ID: 21227600
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of cannabinoids.
Grotenhermen F
Neuro Endocrinol Lett; 2004; 25(1-2):14-23. PubMed ID: 15159677
[TBL] [Abstract][Full Text] [Related]
17. Effects of cannabinoids in the rat model of Huntington's disease generated by an intrastriatal injection of malonate.
Lastres-Becker I; Bizat N; Boyer F; Hantraye P; Brouillet E; Fernández-Ruiz J
Neuroreport; 2003 May; 14(6):813-6. PubMed ID: 12858038
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutical use of the cannabinoids in psychiatry].
Crippa JA; Zuardi AW; Hallak JE
Braz J Psychiatry; 2010 May; 32 Suppl 1():S56-66. PubMed ID: 20512271
[TBL] [Abstract][Full Text] [Related]
19. Receptor mechanisms underlying the CNS effects of cannabinoids: CB
Hempel B; Xi ZX
Adv Pharmacol; 2022; 93():275-333. PubMed ID: 35341569
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information.
Ranganathan M; Radhakrishnan R; Addy PH; Schnakenberg-Martin AM; Williams AH; Carbuto M; Elander J; Pittman B; Andrew Sewell R; Skosnik PD; D'Souza DC
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):176-183. PubMed ID: 28642081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
